HTAsiaLink Annual Conference 2022

10^th HTAsiaLink

CONFERENCE 2022

The Role of HTA in the New Normal :
Driving the post COVID health system through evidence-informed decisions

30 November - 2 December 2022

Accecpted abstracts will be announced on 30 September 2022

About the conference

The 10th HTAsiaLink

The 10th HTAsiaLink Conference would be happening under the theme

The Role of HTA in the New Normal: Driving the post COVID health system through evidence-informed decisions.

With COVID-19 still hitting hard, treatment and epidemiological paradigms have been challenged and changed. New innovations and approaches to health system optimiszation and disruption, such as big data, real-world evidence, etc. become more prominent. In the new normal, health technology assessment (HTA) is more needed than before to ensure the continued sustainability of healthcare systems in 2022 and beyond.

Let’s be a part of the discussion on how the role of HTA will be in the world after COVID-19 pandemic in this HTAsiaLink Annual Conference 2022, which marks 10th anniversary of HTAsiaLink network. It is the time to learn and exchange, celebrate the special occasions and make memories together! We are open for all organizations to play a part in the next regional and international HTA conference and share with us your completed or work-in progress research studies for oral and poster presentations.

HTAsiaLink Annual Conference is a member-only event. However, pre-conference sessions are open to everyone who are interested.

If you are interested to be a member, please contact htasialinkconf@hitap.net, htasialink2022@hitap.net

About Plenary

Plenary Session

The COVID-19 pandemic will have a lasting impact on the world and highlights the need for changes in health systems as well as HTA to support health decision making. How prepared health systems need to be to respond to unexpected changes? What should post-COVID-19 research focus on? Let’s explore how health systems and HTA may adjust in responses to changes post-COVID-19 settings.

Real-world evidence (RWE), derived from real-world data, is gaining increasing interest for its use in HTA. In the past, there had been a number of issues raised and opinions expressed especially with regard to challenges ensuring reliable RWE for HTA and the value of RWE for the purposes of health care decision-making. As RWE is needed and can play a significant role, where RWE will be in the future?

Disruptive technology continues to bring changes to healthcare. Telemedicine has played a big part during the pandemic. Robotic surgery and precision medicines also help improve the outcome of procedures and treatments. In addition, AI, as an enabler for disruptive innovation, is one of the areas at the forefront of changes. However, are these disruptive technologies the way to go, and if it is, how to optimise the results?

Pre-Conference

Registration

HTAsiaLink Annual Conference is a member-only event. While HTAsiaLink members can attend both pre-conference and the main conference, only pre-conference sessions are open to everyone interested. Please register according to your membership type.

Registration closed

Registration opens now until 15 October 2022. Early bird registration by 30 September 2022 will get a free printed copy of the ‘Non-Communicable Disease Prevention: Best Buys, Wasted Buys and Contestable Buys’ (https://www.buyitbestncd.health) at the event!

Conference 2022

Speakers

SCHEDULE AND AGENDA

Agenda

At Royal Cliff Grand Hotel, Pattaya, Thailand - 30 November - 2 December 2022

DOWNLOAD SCHEDULE

7:30-8:00

Registration

1st Floor | Building: Royal Cliff Grand Hotel

8:00-9:20

8:00 – 9:20 (1:20 hrs)

Pre-conference Session 1

Title: The Lifecycle 2.0 - Theinclusion of heath needs

Session lead: international HealthTechScan (i-HTS, former EuroScan international network)

Speakers:

Hans-Peter Dauben
Maximilian Otte

8:00 – 8:30 (30 mins)

Pre-conference Session 2

Title: Report of the HTAi Asia Policy Forum, December 2021

Speakers: Professor Brendon Kearney

8:00 – 9:20 (1:20 hrs)

Pre-conference Session 3

Title: Understanding the Development of Health Technology Assessment in Countries

Session lead: World Health Organization and Postgraduate Institute of Medical Education and Research, Chandigarh, India

Speakers:

Tessa Edejer
Prof Shankar Prinja
Andrew Mirelman
Gaurav Jyani

9:20-9:35

Break

9:35-10:55

9:35 – 10:55 (1:20 hrs)

Pre-conference Session 4

Title: Using infectious disease models from epidemic, pandemic to endemic stage: A lifecycle approach

Session lead: London School of Hygiene & Tropical Medicine (LSHTM), University of Philippines, National University of Singapore, Health Intervention and Technology Assessment Program (HITAP)

Speakers:

Professor Mark Jit
Dr. Hannah Clapham
Dr. Kesha Prem
Dr. Yang Liu
Paul Pasco
Dr. Pritaporn Kingkaew

9:35 – 10:55 (1:20 hrs)

Pre-conference Session 5

Title: Publishing your work – tips for success

Session lead: International Journal of Technology Assessment in Health Care, Changi General Hospital and Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S)‎

Speakers:

A/Prof Wendy Babidge
Dr. Keng Ho Pwee
Dr. Dannii Dougherty
Danielle Stringer

9:35 – 10:55 (1:20 hrs)

Pre-conference Session 6

Title: Bringing Equity into the Health Technology Assessment Discussion

Session lead: Health Economics Unit, Centre for Health Policy, Melbourne School of Population and Global Health, University of Melbourne

Speakers:

Prof Richard Cookson
Natalie Carvalho
Kyoko Shimamoto

10:55-11:10

Refreshment break

Building: Royal Cliff Grand Hotel

11:10-12:30

11:10 - 12:30 (1:20 hrs)

Pre-conference Session 7

Title: Strengthening HTA capacity

Session lead: Imperial College London, Health Intervention and Technology Assessment Program (HITAP)

Speakers:

Dr. Hugo Turner
Dr. Auliya A. Suwantika
Manit Sittimart
Madison Silzle

11:10 - 12:30 (1:20 hrs)

Pre-conference Session 8

Title: Confluence of HTA and Digital Health Technologies

Session lead: Health Intervention and Technology Assessment Program (HITAP), University of Sydney, Ewha Womans University, National University of Singapore

Speakers:

Prof. Jeonghoon Ahn
Dr. Anna Janssen
Assoc Prof. Sarah Norris
Nikita Kanumoory Mandyam
Dr. Pritaporn Kingkaew

11:10 - 12:30 (1:20 hrs)

Pre-conference Session 9

Title: Beyond Checking The Boxes: Guidance of the Joint HTAi – ISPOR Task Force Deliberative Processes For HTA

Session lead: HTAi - ISPOR Task Force

Speakers:

Dr. Wija Oortwin
Prof. Shankar Prinja
Dr. Yot Teerawattananon
Dr. Izzuna Mudla Mohamed Ghazali
Ying-Li (Tommy) Chen
Dana Bayani

12:30-13:30

Lunch

Grand Deck | 2nd Floor | Building: Royal Cliff Grand Hotel

13:30-15:00

Opening Ceremony

Head of State Chamber | 2nd Floor | Building: Royal Cliff Grand Hotel

Opening Speech

Professor Vicharn Panich, M.D. Chairman, Health Intervention and Technology Assessment Program Foundation (HITAP Foundation)

Keynote Speech

Dr. Rungrueng Kitphati, M.D. Advisor and Spokesperson of the Ministry of Public Health, Thailand

Dr. Nopporn Cheanklin, M.D. MPHM (TBC) Executive Director of Health Systems Research Institute (HSRI), Thailand

Dr. Jos Vandelaer World Health Organization Representative, Thailand

Dr. Zhao Kun (Video) President, HTAsiaLink President 2021 – 2022 Division Director of HTA, China National Health Development Research Center (CNHDRC)

10th Anniversary VDO Presentation

Group photo session

15:00-15:15

Refreshment break

Building: Royal Cliff Grand Hotel

15:15-16:35

Plenary 1: Reimagining the Post COVID-19 Health System and HTA

Head of State Chamber | 2nd Floor | Building: Royal Cliff Grand Hotel

Topics	Speakers
Introduction of session and panel/speakers Overview of session and topic including Global trends in post-COVID-19 research and implication of HTA	Eric Arndt, Director of the Asia Regional Office, Rockefeller Foundation
Taking the long view: Investing in institutionalizing HTA before, during and after the pandemic from Indian’s experience	Dr. Shankar Prinja, Executive Director (Health Policy & Quality Assurance), National Health Authority, Government of India
What will be the role of patients in HTA in the post-COVID-19 era? A perspective from Taiwan	Ying-Li (Tommy) CHEN, Researcher, HTA Division, Center for Drug Evaluation (CDE), Taiwan
Transformation through telehealth during COVID-19 and the role of HTA: South Korea's experiment	Dr. Miyoung Choi, Director of Clinical Evidence Research, Director of NECA GRADE Center, National Evidence-based Healthcare Collaborating Agency (NECA), South Korea
Global perspective on the role of HTA in informing research priorities in the post-COVID-19 era	Dr. Tessa Tan-Torres Edejer, Coordinator of the Unit on Costs, Effectiveness, Expenditure and Priority Setting in the Department of Health Financing and Governance (HGF), World Health Organization
Panel Discussion Q&A	All – moderated by Eric Arndt, Director of the Asia Regional Office, Rockefeller Foundation

Topic: PIntroduction of session and panel/speakers Overview of session and topic including Global trends in post-COVID-19 research and implication of HTA

Eric Arndt, Director of the Asia Regional Office, Rockefeller Foundation

Topic: Taking the long view: Investing in institutionalizing HTA before, during and after the pandemic from Indian’s experience

Dr. Shankar Prinja, Executive Director (Health Policy & Quality Assurance), National Health Authority, Government of India

Topic: PWhat will be the role of patients in HTA in the post-COVID-19 era? A perspective from Taiwan

Ying-Li (Tommy) CHEN, Researcher, HTA Division, Center for Drug Evaluation (CDE), Taiwan

Topic: Transformation through telehealth during COVID-19 and the role of HTA: South Korea's experiment

Dr. Miyoung Choi, Director of Clinical Evidence Research, Director of NECA GRADE Center, National Evidence-based Healthcare Collaborating Agency (NECA), South Korea

Topic: Global perspective on the role of HTA in informing research priorities in the post-COVID-19 era

Dr. Tessa Tan-Torres Edejer, Coordinator of the Unit on Costs, Effectiveness, Expenditure and Priority Setting in the Department of Health Financing and Governance (HGF), World Health Organization

Topic: Panel Discussion, Q&A

All – moderated by Eric Arndt, Director of the Asia Regional Office, Rockefeller Foundation

17:00-18:00

Networking event by the beach: HTA/Health Policy regional and global experts

Optional activity with limited seats provided.

Sunset Terrace Bar | 5th Floor | Building: Royal Cliff Beach Terrace

18:00-21:00

Welcome Dinner

Dress code (optional): Semi-formal, traditional or national costumes are encouraged.

Royal Summit Chamber A & B | 1st Floor | Building: Royal Cliff Beach Hotel

8:30-9:00

Attendee Check-in

9:00-10:20

Plenary 2: Accelerating the Impact of Real-World Evidence in Global HTA Community: The past, the present, and the future

Head of State Chamber | 2nd Floor | Building: Royal Cliff Grand Hotel

Topics	Speakers
Introduction of session and speakers	Dr. Wanrudee Isaranuwatchai, Health Intervention and Technology Assessment (HITAP), Thailand
Strengths and pitfalls of RWE: Lessons from the past	Prof. Erna Kristin, Gadjah Mada University, Indonesia
Exciting use of RWE in research and policy: Current state of art	Dr. Wenjia Chen, Saw Swee Hock School of Public Health, the National University of Singapore (NUS), Singapore
Future of RWE: What is yet to come?	Dr. Jasmine Pwu, National Hepatitis C Program Office, Ministry of Health and Welfare, Taiwan
RWE and policymaking in Thailand	Dr. Lalitaya Kongkam, National health Security Office (NHSO), Thailand
Panel Discussion Q&A	All – moderated by Dr. Wanrudee Isaranuwatchai, Health Intervention and Technology Assessment (HITAP), Thailand

Topics: Introduction of session and speakers

Dr. Wanrudee Isaranuwatchai, Health Intervention and Technology Assessment (HITAP), Thailand

Topics: Strengths and pitfalls of RWE: Lessons from the past

Prof. Erna Kristin, Gadjah Mada University, Indonesia

Topics: Exciting use of RWE in research and policy: Current state of art

Dr. Wenjia Chen, Saw Swee Hock School of Public Health, the National University of Singapore (NUS), Singapore

Topics: Future of RWE: What is yet to come?

Dr. Jasmine Pwu, National Hepatitis C Program Office, Ministry of Health and Welfare, Taiwan

Topics: RWE and policymaking in Thailand

Dr. Lalitaya Kongkam, National health Security Office (NHSO), Thailand

Topics: Panel Discussion, Q&A

All – moderated by Dr. Wanrudee Isaranuwatchai, Health Intervention and Technology Assessment (HITAP), Thailand

10:20-10:40

Refreshment break / Poster viewing

Building: Royal Cliff Grand Hotel

10:40-12:00

Oral Presentation

Track: Economic Evaluation

Room: Head of State Chamber 2nd Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Economic Evaluation

Room: Orchid A 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Health System/Service Research

Room: Orchid B 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Other (Evidence Synthesis, Real-world Evidence, etc.)

Room: Jomtien 2 1st Floor

Building: Royal Cliff Grand Hotel

12:00-13:00

12:00 – 13:00 (1:00 hr)

Lunch

Grand Deck | 2nd Floor

Building: Royal Cliff Grand Hotel

12:30 – 13:00 (30 mins)

Poster Session 1

2nd Floor

Building: Royal Cliff Grand Hotel

13:00-14:20

Oral Presentation

Track: Economic Evaluation

Room: Head of State Chamber 2nd Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Economic Evaluation

Room: Orchid A 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Health System/Service Research

Room: Orchid B 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Other (Evidence Synthesis, Real-world Evidence, etc.)

Room: Jomtien 2 1st Floor

Building: Royal Cliff Grand Hotel

14:20-14:40

Refreshment break and Poster Session 2

2nd Floor

Building: Royal Cliff Grand Hotel

14:40-16:00

Oral Presentation

Track: Economic Evaluation

Room: Head of State Chamber 2nd Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Other (Evidence Synthesis, Real-world Evidence, etc.)

Room: Orchid A 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Health System/Service Research

Room: Orchid B 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Other (Evidence Synthesis, Real-world Evidence, etc.)

Room: Jomtien 2 1st Floor

Building: Royal Cliff Grand Hotel

16:00-16:20

Break & Poster Session 3

2nd Floor

Building: Royal Cliff Grand Hotel

16:20-17:40

Oral Presentation

Track: Economic Evaluation

Room: Head of State Chamber 2nd Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Economic Evaluation

Room: Orchid A 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Health System/Service Research + Other

Room: Orchid B 1st Floor

Building: Royal Cliff Grand Hotel

Oral Presentation

Track: Other (Evidence Synthesis, Real-world Evidence, etc.)

Room: Jomtien 2 1st Floor

Building: Royal Cliff Grand Hotel

18:20-19:20

Abstract Result Discussion

Reserved for Scientific Committee and organizers only

Room: Orchid A 1st Floor

Building: Royal Cliff Grand Hotel

8:30-9:00

Attendee Check-in

9:00-10:20

Plenary Session 3: Searching for the Holy Grail Solution for Our Health Systems: Are Disruptive Technologies the Answer?

Head of State Chamber | 2nd Floor | Building: Royal Cliff Grand Hotel

Topics	Speakers
Overview of rising trends of AI and disruptive technologies in health sector	Dr. Alec Morton, University of Strathclyde
Use cases and lessons learned of disruptive technologies in healthcare from Malaysia	Dr. Syaqirah Akmal, Health Technology Assessment Section (MaHTAS), Ministry of Health, Malaysia
Use cases and lessons learned of disruptive technologies in healthcare from Singapore	Dr. Ho Yan Teck, Agency for Care Effectiveness, Ministry of Health, Singapore Sarah Norris, The University of Sydney, Australia
Panel Discussion Q&A	All – moderated by Dr. Alec Morton, University of Strathclyde

Topic: Overview of rising trends of AI and disruptive technologies in health sector

Dr. Alec Morton, University of Strathclyde

Topic: Use cases and lessons learned of disruptive technologies in healthcare from Malaysia

Dr. Syaqirah Akmal, Health Technology Assessment Section (MaHTAS), Ministry of Health, Malaysia

Topic: Use cases and lessons learned of disruptive technologies in healthcare from Singapore

Dr. Ho Yan Teck, Agency for Care Effectiveness, Ministry of Health, Singapore

Topic: Panel Discussion, Q&A

All – moderated by Dr. Alec Morton, University of Strathclyde

10:20-10:40

Refreshment break

Building: Royal Cliff Grand Hotel

10:40-12:00

Awards Ceremony, Closing Remarks, and Next Host Announcement

Head of State Chamber | 2nd Floor | Building: Royal Cliff Grand Hotel

12:00-13:00

Lunch

Royal Summit Chamber B | 1st Floor | Building: Royal Cliff Beach Hotel

13:30-14:30

HTAsiaLink Member Meeting

Royal Summit Chamber A | 1st Floor | Building: Royal Cliff Beach Hotel

Summary of the conference evaluation

Updates on member status, international collaboration, and endorsed projects

14:30-15:00

HTAsiaLink Council Meeting

Royal Summit Chamber A | 1st Floor | Building: Royal Cliff Beach Hotel

Network elections

15:00-15:20

Refreshment break

15:20-16:00

HTAsiaLink Board Meeting

Royal Summit Chamber A | 1st Floor | Building: Royal Cliff Beach Hotel

11th HTAsiaLink Annual Conference plan

LOGISTICS INFORMATION

Venue

Accommodation and Logistics

Royal Cliff Grand Hotel, Pattaya, Thailand

353 Phra Tamnuk Road, Pattaya, Chonburi, Thailand 20150

The 10th HTAsiaLink Annual Conference will be at Royal Cliff Grand Hotel. For your convenience, to commute to the conference venue, staying at Royal Cliff Hotels Group (Royal Cliff Grand Hotel or Royal Cliff Beach Hotel) is highly recommended. As HTAsiaLink participants, you could also get the group pricing rate. See more details

Google map

ONE-DAY TRIP AT PATTAYA

Local Attractions

Explore Nong Nooch Tropical Botanical Garden

Distance from hotel : 21.9 km

Open : Tue-Sun 8.30 a.m-5.00 p.m. (Closed every Mon)

Brief information : The sprawling park at Nong Nooch (pronounced "nung nut") Village offers a variety of activities for all the family. Walkways wind among colorful themed gardens

Google map

Discover the Sanctuary of Truth

Distance from hotel : 9.9 km

Open : Everyday 8.00 a.m-6.00 p.m.

Brief information : Billed as "the magnificence of heaven recreated on Earth," this massive monument, built entirely of wood, is a study in Thai architectural styles. Every available space is intricately decorated with wooden carvings, and the entire structure was built to pay homage to ancient religions and philosophies.

Google map

Take a Day Trip to Koh Larn (Coral Island)

Distance from hotel : 2.1 km

Brief information : A 30-minute speed boat ride or 45-minute ferry ride from Pattaya, Koh Larn (also called Koh Lan) is a relatively peaceful escape from tourist-packed Pattaya.

Google map

Accepted Abstracts

Please confirm your in-person attendance by replying to the announcement email, and confirming your full name and affiliation by Friday, 7 October 2022 (GMT+7).

Oral
Presentation

Poster
Presentation

Abstract ID	Abstract title	Presenter's full name, organisation, and country	Position
EE01	ECONOMIC BURDEN OF CHEMICAL POISONING IN THAILAND: AN INPUT FOR ECONOMIC EVALUATION OF TOXICITY INTERVENTIONS	Mu Htay Kywel, Mahidol University, Thailand	Postgraduate Student
EE05	An expert elicitation to estimate the counterfactual scenario costs and outcomes for economic evaluation of precision medicines.	Chotika Suwanpanich, Health Intervention and Technology Assessment Program (HITAP), Thailand	research assistant
EE06	Cost-effectiveness of Neoadjuvant treatment with dual anti-HER2 therapy for HER2 positive breast cancer	Danushi Mendis Gunasekara, Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Thailand; Faculty of Medicine, General Sir John Kotelawala Defence University, Sri Lanka	PhD student
EE07	Cost-effectiveness Analysis of Typhoid Fever Vaccination in Lao PDR	Mick Soukavong, University of Health Sciences, Lao PDR	Lecturer
EE08	Cost Benefit Analysis of Alternative Testing and Quarantine Policies for Travellers for Infection Control: a Case Study of Singapore during the COVID-19 Pandemic	Celestine Grace Cai XueTing, National University of Singapore, Singapore	Research Associate
EE12	Cost-utility analysis of pneumococcal conjugate vaccine (PCV) in Thailand context: A review and updated analysis	Parntip Juntama, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research assistant
EE13	ECONOMIC EVALUATION OF GENETIC TESTING FOR THALASSEMIA CARRIER DIAGNOSIS AMONG MARRIED COUPLE IN THAILAND	Kwandao Malasai, HTA, Mahidol University, Thailand	graduate student
EE14	Economic evaluation of screening and prevention options for elderly and postmenopausal osteoporosis.	Nicha Moonkham, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research assistant
EE15	Economic Evaluation of Using Sewage Surveillance to Inform Lockdown Decisions at the Early Phase of a Pandemic: A Simulation Study Considering COVID-19 in Singapore	WANG YI, Saw Swee Hock School of Public Health, National University of Singapore, Singapore	Senior research fellow
EE18	Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India	Sitanshu Sekhar Kar, JIPMER, Puducherry, India, India	Prof of Preventive & Social Medicine, Principal Investigator of HTAIn Resource Center, JIPMER, Puducherry
EE19	Economic evaluation of rotavirus vaccination in children of Bhutan	Pempa, Essential medicines and Technology Division, Ministry of Health, Bhutan	Sr. Program Officer
EE21	ECONOMIC EVALUATION OF GENETIC TESTING FOR PRENATAL SCREENING FETAL ANEUPLOIDIES IN THAILAND	Preechaya Wongkrajang, Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Faculty of Pharmacy, Mahidol University, Thailand	Ph.D student
EE22	Economic evaluation of exome sequencing for infantile intractable epilepticus	Thamonwan Dulsamphan, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research assistant
EE24	COST-UTILITY ANALYSIS AND BUDGET IMPACT OF DIALYSIS MODALITIES IN END-STAGE RENAL DISEASE: EVIDENCE FOR COVERAGE DECISIONS IN KENYA	Patricia Nyokabi Njuguna, Mahidol University Health Technology Assessment (MUHTA) Program, Thailand	Masters Student
EE25	Economic Evaluation on Cervical Cancer Screening Using HPV-DNA, VIA, and Pap-Smear in Indonesia	Firdaus Hafidz, MD, MPH, PhD, Universitas Gadjah Mada/Ministry of Health Indonesia, Indonesia	Lecturer/Researcher
EE27	A model-based study to estimate the health and economic impact of health technology assessment in Thailand	Chris Painter, Mahidol-Oxford Tropical Medicine Research Unit, Thailand	Health Economist
EE30	Economic Evaluation and Budget Impact Analysis of Endovascular Treatment for Acute Ischemic Stroke in a Developing Country	Budsadee Soboon, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research assistant
EE32	Economic evaluation of Evusheld for pre-exposure prevention of COVID-19 in high-risk populations	Chittawan Poonsiri, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate
EE33	Economic Evaluation of Casirivimab+Imdevimab as treatment for patients with COVID-19	Joshua F. Santillan, HTA Philippines (Department of Health - Philippines), Philippines	Health Program Officer II - Policy, Planning, and Evaluation Unit
EE35	Cost-utility analysis of community-based interventions for hypertension control in Vietnam	Viet Tuan Nguyen, Health Strategy and Policy Institute, Vietnam	Researcher
EE36	Cost-effectiveness comparison of PD-(L)1 inhibitors in first-line treatment of advanced non-squamous non-small cell lung cancer in China	Yi Yang, Fudan University, China	Postdoctoral fellow
EE37	BUDGET IMPACT ANALYSIS OF DIRECT-ACTING ANTIVIRALS IN CHRONIC HEPATITIS C TREATMENT IN VIETNAM	Due Ong The, Health Strategy and Policy Institute, Vietnam	Researcher
EE45	Cost-effectiveness of cervical cancer prevention: comparison of screening policies after mass vaccination	Yong-Chen Chen, Fu Jen Catholic University, Taiwan
HS03	COMPARATIVE ASSESSMENT OF IV AND SC RITUXIMAB FOR PATIENTS WITH NON-HODGKIN’S LYMPHOMA: A RAPID REVIEW	Princess Allyza B. Mondala, DOH HTA Division Philippines, Philippines	Senior Health Program Officer
HS04	Development of the Social Values Guide to Health Technology Assessment (HTA) in the Philippines	Tisha Isabelle M. de Vergara, HTA Division, Department of Health Philippines, Philippines	Senior Health Program Officer
HS12	A rapid assessment of pulse oximeter for screening of CCHD in newborns in Thailand.	Jiratorn Sutawong, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research Assistant
HS14	A COVID-19 Vaccination Certificates initiative for the Asian region?: a survey from nine countries in Asia	Chayapat Rachatan, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate
HS21	Ethical, Legal, Social, and Health Systems Impact (ELSHI) Assessment of Self-Administered Antigen Test for COVID-19 in the Philippines	Jayne Eunice U. Yang, Department of Health Philippines, Philippines	Health Program Officer II
HS24	Global, regional, and country level estimate of borrowing money for healthcare payment in 2014 and 2017: a comparative analysis	Md Rashedul Islam, Hitotsubashi University, Japan	Research Associate
HS25	Situational analysis: the Lao health policy decision-making context	Dr. Sysavanh Phommachanh M.D., MSc., Ph.D, University of Health Sciences, Lao PDR, Laos	Vice-Director General of Institute of Research and Education Development, University of Health Sciences, Lao PDR
HS26	Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India	Yashika Chugh, Post Graduate Institute of Medical Education and Research, Chandigarh, India, India	Senior Research Officer, PhD Scholar
HS29	The Relative Importance of Vulnerability and Efficiency in COVID-19 Contact Tracing Programmes: A Discrete Choice Experiment	Dian Faradiba, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate
HS30	Relationship between diabetic knowledge, attitudes, and practices among Chinese diabetes patients: A structural equation model	Wenjun Zhu, Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China, China	PhD student
HS32	Assessment of Greenhouse Gas (GHG) Emissions from Public Healthcare Facilities in Thailand	Ella Nanda Sari, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate
HS36	Impact of financial subsidies on oral health care utilisation among persons with disabilities	Tan Hui Xuan Sharon, NUS SSHSPH, Singapore	RF
HS41	PERCEPTIONS OF PATIENTS TOWARD THE MANAGEMENT OF RARE DISEASE IN MALAYSIA: A QUALITATIVE STUDY	AZUWANA SUPIAN, Pharmaceutical Services Programme, Ministry of Health Malaysia, Malaysia	Pharmacist
HS43	The Impact of the COVID-19 Pandemic on Hospital Operations and Staff Experience: Lessons from a Large Integrated Hospital System in Ottawa, Canada	Kednapa Thavorn, Ottawa Hospital Research Institute, Canada	Senior Scientist
HS44	HEALTH TECHNOLOGY ASSESSMENTS FOR RARE DISEASES IN AUSTRALIA: A CASE STUDY ON CYSTIC FIBROSIS	Himani Jaiswal, Evidera, Part of Thermo Fisher Scientific, India	Senior Business Analyst
OT01	Evaluation of Intraoperative Hypotension Burden Model in Korea using HIRA National Inpatient Sample (HIRA-NIS) Data	Seonghee Nam, Ewha Womans University, South Korea	Graduate student
OT05	A systematic review of health economic evaluations in the Philippines	Mac Ardy Junio Gloria, Mahidol University / UP Manila, Philippines	Student / Lecturer
OT07	Longer Survival or Better Quality of Life? Preference of Clinicians treating cancer patients in Malaysia’s public hospitals	Haarathi Chandriah, Pharmaceutical Services Programme, Ministry of Health Malaysia, Malaysia	Pharmacist
OT09	Health- Related Quality of Life among the Indian Population: The EQ-5D Population Norms for India	Gaurav Jyani, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, India	Economic Evaluation Specialist
OT10	Impact of Adverse Drug Reactions (ADRs) among Hospitalized Patients’ Health-related Quality of Life (HRQoL): A Cross-sectional study in Malaysia’s MOH State Hospitals	Siti Fauziah Abu, Pharmaceutical Services Program, Ministry of Health Malaysia, Malaysia	Senior Principal Assistant Director
OT12	Moving healthcare system in Thailand more value based through low-value care: COVID-19’s natural experiment	Jarawee Sukmanee, Health Intervention and Technology Assessment Program, Thailand	Researcher
OT13	Economic costs of alcohol consumption in Thailand, 2021	Chaisiri Luangsinsiri, Mahidol University, Thailand	Ph.D. student
OT15	High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic: First Wave Data in Thailand	Picharee Karunayawong, Health Intervention and Technology Assessment Program (HITAP), Thailand	Researcher
OT16	Pre-Dialysis Education Program for Advanced Chronic Kidney Disease (CKD): A Systematic Review	Nur Farhana Mohamad, Malaysian Health Technology Assessment Section (MaHTAS), Malaysia	Reviewer
OT18	APPLICATION OF MULTI CRITERIA DECISION ANALYSIS (MCDA) USING ANALYTICAL HIERARCHY PROCESS (AHP) APPROACH IN WEIGHTING THE HTA TOPIC SELECTION CRITERIA IN INDONESIA	Rozar Prawiranegara, Management Sciences for Health, Indonesia	HTA Technical Advisor
OT19	ELICITING VALUE FOR HTA TOPIC SELECTION CRITERIA IN INDONESIA USING DELPHI METHOD AND DELIBERATIVE PROCESSES	mutia anggun sayekti, Management Sciences for Health, Indonesia	USAID MTaPS Consultant
OT21	Systematic review and Network meta-analysis of Novel Anti-Diabetic Agents in the Treatment of Non-Alcoholic Fatty Liver Disease.	Tanawan Kongmalai, Mahidol University, Thailand	Assistant Professor
OT23	Adaptive health technology assessments to inform oncology based priority setting in India	Srobana Ghosh, CGD at iDSI, United Kingdom	Policy analyst
OT27	Efficacy and safety of perindopril and amlodipine fixed-dose combination for hypertension treatment：a Meta-analysis	GUO HUANG, Science and Technology Development Center of Chinese Pharmaceutical Association, Beijing, China	assistant researcher
OT28	A systematic review of methods for valuing productivity losses due to illness in low-and middle-income countries (LMICs)	Ery Setiawan, Charles Darwin University, Australia	PhD student
OT29	WHAT DOES NEWER GUIDANCE ON COST-EFFECTIVENESS THRESHOLDS MEAN FOR PNEUMOCOCCAL CONJUGATE VACCINE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?	Natalie Carvalho, University of Melbourne, Australia	Senior Research Fellow
OT32	A systematic review of economic evaluations of cochlear implant therapy for hearing impairment around the world	Di Wu, China National Health Development Research Center, China	intern-researcher
OT34	How socioeconomic status and the public sector affected the access to diagnosis of malaria in children under five: findings from 19 sub-Saharan African Countries	Ge Yue, Fudan University, China	PhD candidate
OT37	VIDEO ASSISTED THORACOSCOPIC SURGERY VERSUS OPEN SURGERY FOR NON-SMALL CELL LUNG CANCER IN ELDERLY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS	Jungeun Park, National Evidence-based Healthcare Collaborating Agency, South Korea	Researcher
OT38	Efficacy and safety of monoclonal antibody in patients with neuromyelitis optica spectrum disorder: a systematic review and network meta-analysis	Saharat Aungsumart, Neurological institute of Thailand, Thailand	Physician
OT40	Mucosal Integrity Testing: systematic review	JINA MO, National Evidence-based Healthcare Collaborating Agency(NECA), South Korea	Associate Research Fellow
OT45	Depressed and depression-prone groups preference with regard to antidepressants in China: a best-worst scaling survey	Yanfeng Ren, Fudan university, China	None
OT47	The Economic Evaluation of Screening and Early Diagnosis of Primary Immunodeficiency Diseases: A Systematic Review	Fan Zhang, Wanke School of Public Health, Tsinghua University, China	Research Assistant
OT48	A scoping review on the transmission of multidrug-resistant organisms in healthcare network settings from a systematic perspective.	Yixue Guo, Fudan University, China	Student
OT55	Measuring the direct nonmedical cost associated with advanced non-small cell lung cancer in China: Is there a difference in health status?	Yu Xia, NHC Key Lab of Health Technology Assessment, School of Public Health, Fudan University, Shanghai, China, China	PhD student
OT56	Health-related quality of life for caregivers of patients with advanced non-small cell lung cancer in China	Liu Liu, Fudan university, China	PhD student

Abstract ID : EE01

Abstract title : ECONOMIC BURDEN OF CHEMICAL POISONING IN THAILAND: AN INPUT FOR ECONOMIC EVALUATION OF TOXICITY INTERVENTIONS

Presenter's full name, organisation, and country : Mu Htay Kywel, Mahidol University, Thailand

Position : Postgraduate Student

Abstract ID : EE05

Abstract title : An expert elicitation to estimate the counterfactual scenario costs and outcomes for economic evaluation of precision medicines.

Presenter's full name, organisation, and country : Chotika Suwanpanich, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : research assistant

Abstract ID : EE06

Abstract title : Cost-effectiveness of Neoadjuvant treatment with dual anti-HER2 therapy for HER2 positive breast cancer

Presenter's full name, organisation, and country : Danushi Mendis Gunasekara, Mahidol University Health Technology Assessment Graduate Program, Mahidol University, Thailand; Faculty of Medicine, General Sir John Kotelawala Defence University, Sri Lanka

Position : PhD student

Abstract ID : EE07

Abstract title : Cost-effectiveness Analysis of Typhoid Fever Vaccination in Lao PDR

Presenter's full name, organisation, and country : Mick Soukavong, University of Health Sciences, Lao PDR

Position : Lecturer

Abstract ID : EE08

Abstract title : Cost Benefit Analysis of Alternative Testing and Quarantine Policies for Travellers for Infection Control: a Case Study of Singapore during the COVID-19 Pandemic

Presenter's full name, organisation, and country : Celestine Grace Cai XueTing, National University of Singapore, Singapore

Position : Research Associate

Abstract ID : EE12

Abstract title : Cost-utility analysis of pneumococcal conjugate vaccine (PCV) in Thailand context: A review and updated analysis

Presenter's full name, organisation, and country : Parntip Juntama, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research assistant

Abstract ID : EE13

Abstract title : ECONOMIC EVALUATION OF GENETIC TESTING FOR THALASSEMIA CARRIER DIAGNOSIS AMONG MARRIED COUPLE IN THAILAND

Presenter's full name, organisation, and country : Kwandao Malasai, HTA, Mahidol University, Thailand

Position : graduate student

Abstract ID : EE14

Abstract title : Economic evaluation of screening and prevention options for elderly and postmenopausal osteoporosis.

Presenter's full name, organisation, and country : Nicha Moonkham, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research assistant

Abstract ID : EE15

Abstract title : Economic Evaluation of Using Sewage Surveillance to Inform Lockdown Decisions at the Early Phase of a Pandemic: A Simulation Study Considering COVID-19 in Singapore

Presenter's full name, organisation, and country : WANG YI, Saw Swee Hock School of Public Health, National University of Singapore, Singapore

Position : Senior research fellow

Abstract ID : EE18

Abstract title : Cost-effectiveness of implementing risk-based cardiovascular disease (CVD) management using updated WHO CVD risk prediction charts in India

Presenter's full name, organisation, and country : Sitanshu Sekhar Kar, JIPMER, Puducherry, India, India

Position : Prof of Preventive & Social Medicine, Principal Investigator of HTAIn Resource Center, JIPMER, Puducherry

Abstract ID : EE19

Abstract title : Economic evaluation of rotavirus vaccination in children of Bhutan

Presenter's full name, organisation, and country : Pempa, Essential medicines and Technology Division, Ministry of Health, Bhutan

Position : Sr. Program Officer

Abstract ID : EE21

Abstract title : ECONOMIC EVALUATION OF GENETIC TESTING FOR PRENATAL SCREENING FETAL ANEUPLOIDIES IN THAILAND

Presenter's full name, organisation, and country : Preechaya Wongkrajang, Social, Economic and Administrative Pharmacy (SEAP) Graduate Program, Faculty of Pharmacy, Mahidol University, Thailand

Position : Ph.D student

Abstract ID : EE22

Abstract title : Economic evaluation of exome sequencing for infantile intractable epilepticus

Presenter's full name, organisation, and country : Thamonwan Dulsamphan, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research assistant

Abstract ID : EE24

Abstract title : COST-UTILITY ANALYSIS AND BUDGET IMPACT OF DIALYSIS MODALITIES IN END-STAGE RENAL DISEASE: EVIDENCE FOR COVERAGE DECISIONS IN KENYA

Presenter's full name, organisation, and country : Patricia Nyokabi Njuguna, Mahidol University Health Technology Assessment (MUHTA) Program, Thailand

Position : Masters Student

Abstract ID : EE25

Abstract title : Economic Evaluation on Cervical Cancer Screening Using HPV-DNA, VIA, and Pap-Smear in Indonesia

Presenter's full name, organisation, and country : Firdaus Hafidz, MD, MPH, PhD, Universitas Gadjah Mada/Ministry of Health Indonesia, Indonesia

Position : Lecturer/Researcher

Abstract ID : EE27

Abstract title : A model-based study to estimate the health and economic impact of health technology assessment in Thailand

Presenter's full name, organisation, and country : Chris Painter, Mahidol-Oxford Tropical Medicine Research Unit, Thailand

Position : Health Economist

Abstract ID : EE30

Abstract title : Economic Evaluation and Budget Impact Analysis of Endovascular Treatment for Acute Ischemic Stroke in a Developing Country

Presenter's full name, organisation, and country : Budsadee Soboon, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research assistant

Abstract ID : EE32

Abstract title : Economic evaluation of Evusheld for pre-exposure prevention of COVID-19 in high-risk populations

Presenter's full name, organisation, and country : Chittawan Poonsiri, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

Abstract ID : EE33

Abstract title : Economic Evaluation of Casirivimab+Imdevimab as treatment for patients with COVID-19

Presenter's full name, organisation, and country : Joshua F. Santillan, HTA Philippines (Department of Health - Philippines), Philippines

Position : Health Program Officer II - Policy, Planning, and Evaluation Unit

Abstract ID : EE35

Abstract title : Cost-utility analysis of community-based interventions for hypertension control in Vietnam

Presenter's full name, organisation, and country : Viet Tuan Nguyen, Health Strategy and Policy Institute, Vietnam

Position : Researcher

Abstract ID : EE36

Abstract title : Cost-effectiveness comparison of PD-(L)1 inhibitors in first-line treatment of advanced non-squamous non-small cell lung cancer in China

Presenter's full name, organisation, and country : Yi Yang, Fudan University, China

Position : Postdoctoral fellow

Abstract ID : EE37

Abstract title : BUDGET IMPACT ANALYSIS OF DIRECT-ACTING ANTIVIRALS IN CHRONIC HEPATITIS C TREATMENT IN VIETNAM

Presenter's full name, organisation, and country : Due Ong The, Health Strategy and Policy Institute, Vietnam

Position : Researcher

Abstract ID : EE45

Abstract title : Cost-effectiveness of cervical cancer prevention: comparison of screening policies after mass vaccination

Presenter's full name, organisation, and country : Yong-Chen Chen, Fu Jen Catholic University, Taiwan

Position :

Abstract ID : HS03

Abstract title : COMPARATIVE ASSESSMENT OF IV AND SC RITUXIMAB FOR PATIENTS WITH NON-HODGKIN’S LYMPHOMA: A RAPID REVIEW

Presenter's full name, organisation, and country : Princess Allyza B. Mondala, DOH HTA Division Philippines, Philippines

Position : Senior Health Program Officer

Abstract ID : HS04

Abstract title : Development of the Social Values Guide to Health Technology Assessment (HTA) in the Philippines

Presenter's full name, organisation, and country : Tisha Isabelle M. de Vergara, HTA Division, Department of Health Philippines, Philippines

Position : Senior Health Program Officer

Abstract ID : HS12

Abstract title : A rapid assessment of pulse oximeter for screening of CCHD in newborns in Thailand.

Presenter's full name, organisation, and country : Jiratorn Sutawong, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research Assistant

Abstract ID : HS14

Abstract title : A COVID-19 Vaccination Certificates initiative for the Asian region?: a survey from nine countries in Asia

Presenter's full name, organisation, and country : Chayapat Rachatan, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

Abstract ID : HS21

Abstract title : Ethical, Legal, Social, and Health Systems Impact (ELSHI) Assessment of Self-Administered Antigen Test for COVID-19 in the Philippines

Presenter's full name, organisation, and country : Jayne Eunice U. Yang, Department of Health Philippines, Philippines

Position : Health Program Officer II

Abstract ID : HS24

Abstract title : Global, regional, and country level estimate of borrowing money for healthcare payment in 2014 and 2017: a comparative analysis

Presenter's full name, organisation, and country : Md Rashedul Islam, Hitotsubashi University, Japan

Position : Research Associate

Abstract ID : HS25

Abstract title : Situational analysis: the Lao health policy decision-making context

Presenter's full name, organisation, and country : Dr. Sysavanh Phommachanh M.D., MSc., Ph.D, University of Health Sciences, Lao PDR, Laos

Position : Vice-Director General of Institute of Research and Education Development, University of Health Sciences, Lao PDR

Abstract ID : HS26

Abstract title : Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India

Presenter's full name, organisation, and country : Yashika Chugh, Post Graduate Institute of Medical Education and Research, Chandigarh, India, India

Position : Senior Research Officer, PhD Scholar

Abstract ID : HS29

Abstract title : The Relative Importance of Vulnerability and Efficiency in COVID-19 Contact Tracing Programmes: A Discrete Choice Experiment

Presenter's full name, organisation, and country : Dian Faradiba, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

Abstract ID : HS30

Abstract title : Relationship between diabetic knowledge, attitudes, and practices among Chinese diabetes patients: A structural equation model

Presenter's full name, organisation, and country : Wenjun Zhu, Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China, China

Position : PhD student

Abstract ID : HS32

Abstract title : Assessment of Greenhouse Gas (GHG) Emissions from Public Healthcare Facilities in Thailand

Presenter's full name, organisation, and country : Ella Nanda Sari, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

Abstract ID : HS36

Abstract title : Impact of financial subsidies on oral health care utilisation among persons with disabilities

Presenter's full name, organisation, and country : Tan Hui Xuan Sharon, NUS SSHSPH, Singapore

Position : RF

Abstract ID : HS41

Abstract title : PERCEPTIONS OF PATIENTS TOWARD THE MANAGEMENT OF RARE DISEASE IN MALAYSIA: A QUALITATIVE STUDY

Presenter's full name, organisation, and country : AZUWANA SUPIAN, Pharmaceutical Services Programme, Ministry of Health Malaysia, Malaysia

Position : Pharmacist

Abstract ID : HS43

Abstract title : The Impact of the COVID-19 Pandemic on Hospital Operations and Staff Experience: Lessons from a Large Integrated Hospital System in Ottawa, Canada

Presenter's full name, organisation, and country : Kednapa Thavorn, Ottawa Hospital Research Institute, Canada

Position : Senior Scientist

Abstract ID : HS44

Abstract title : HEALTH TECHNOLOGY ASSESSMENTS FOR RARE DISEASES IN AUSTRALIA: A CASE STUDY ON CYSTIC FIBROSIS

Presenter's full name, organisation, and country : Himani Jaiswal, Evidera, Part of Thermo Fisher Scientific, India

Position : Senior Business Analyst

Abstract ID : OT01

Abstract title : Evaluation of Intraoperative Hypotension Burden Model in Korea using HIRA National Inpatient Sample (HIRA-NIS) Data

Presenter's full name, organisation, and country : Seonghee Nam, Ewha Womans University, South Korea

Position : Graduate student

Abstract ID : OT05

Abstract title : A systematic review of health economic evaluations in the Philippines

Presenter's full name, organisation, and country : Mac Ardy Junio Gloria, Mahidol University / UP Manila, Philippines

Position : Student / Lecturer

Abstract ID : OT07

Abstract title : Longer Survival or Better Quality of Life? Preference of Clinicians treating cancer patients in Malaysia’s public hospitals

Presenter's full name, organisation, and country : Haarathi Chandriah, Pharmaceutical Services Programme, Ministry of Health Malaysia, Malaysia

Position : Pharmacist

Abstract ID : OT09

Abstract title : Health- Related Quality of Life among the Indian Population: The EQ-5D Population Norms for India

Presenter's full name, organisation, and country : Gaurav Jyani, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, India

Position : Economic Evaluation Specialist

Abstract ID : OT10

Abstract title : Impact of Adverse Drug Reactions (ADRs) among Hospitalized Patients’ Health-related Quality of Life (HRQoL): A Cross-sectional study in Malaysia’s MOH State Hospitals

Presenter's full name, organisation, and country : Siti Fauziah Abu, Pharmaceutical Services Program, Ministry of Health Malaysia, Malaysia

Position : Senior Principal Assistant Director

Abstract ID : OT12

Abstract title : Moving healthcare system in Thailand more value based through low-value care: COVID-19’s natural experiment

Presenter's full name, organisation, and country : Jarawee Sukmanee, Health Intervention and Technology Assessment Program, Thailand

Position : Researcher

Abstract ID : OT13

Abstract title : Economic costs of alcohol consumption in Thailand, 2021

Presenter's full name, organisation, and country : Chaisiri Luangsinsiri, Mahidol University, Thailand

Position : Ph.D. student

Abstract ID : OT15

Abstract title : High-Cost Users Still Came to Hospitals During the COVID-19 Pandemic: First Wave Data in Thailand

Presenter's full name, organisation, and country : Picharee Karunayawong, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Researcher

Abstract ID : OT16

Abstract title : Pre-Dialysis Education Program for Advanced Chronic Kidney Disease (CKD): A Systematic Review

Presenter's full name, organisation, and country : Nur Farhana Mohamad, Malaysian Health Technology Assessment Section (MaHTAS), Malaysia

Position : Reviewer

Abstract ID : OT18

Abstract title : APPLICATION OF MULTI CRITERIA DECISION ANALYSIS (MCDA) USING ANALYTICAL HIERARCHY PROCESS (AHP) APPROACH IN WEIGHTING THE HTA TOPIC SELECTION CRITERIA IN INDONESIA

Presenter's full name, organisation, and country : Rozar Prawiranegara, Management Sciences for Health, Indonesia

Position : HTA Technical Advisor

Abstract ID : OT19

Abstract title : ELICITING VALUE FOR HTA TOPIC SELECTION CRITERIA IN INDONESIA USING DELPHI METHOD AND DELIBERATIVE PROCESSES

Presenter's full name, organisation, and country : mutia anggun sayekti, Management Sciences for Health, Indonesia

Position : USAID MTaPS Consultant

Abstract ID : OT21

Abstract title : Systematic review and Network meta-analysis of Novel Anti-Diabetic Agents in the Treatment of Non-Alcoholic Fatty Liver Disease.

Presenter's full name, organisation, and country : Tanawan Kongmalai, Mahidol University, Thailand

Position : Assistant Professor

Abstract ID : OT23

Abstract title : Adaptive health technology assessments to inform oncology based priority setting in India

Presenter's full name, organisation, and country : Srobana Ghosh, CGD at iDSI, United Kingdom

Position : Policy analyst

Abstract ID : OT27

Abstract title : Efficacy and safety of perindopril and amlodipine fixed-dose combination for hypertension treatment：a Meta-analysis

Presenter's full name, organisation, and country : GUO HUANG, Science and Technology Development Center of Chinese Pharmaceutical Association, Beijing, China

Position : assistant researcher

Abstract ID : OT28

Abstract title : A systematic review of methods for valuing productivity losses due to illness in low-and middle-income countries (LMICs)

Presenter's full name, organisation, and country : Ery Setiawan, Charles Darwin University, Australia

Position : PhD student

Abstract ID : OT29

Abstract title : WHAT DOES NEWER GUIDANCE ON COST-EFFECTIVENESS THRESHOLDS MEAN FOR PNEUMOCOCCAL CONJUGATE VACCINE PROGRAMS IN LOW- AND MIDDLE-INCOME COUNTRIES?

Presenter's full name, organisation, and country : Natalie Carvalho, University of Melbourne, Australia

Position : Senior Research Fellow

Abstract ID : OT32

Abstract title : A systematic review of economic evaluations of cochlear implant therapy for hearing impairment around the world

Presenter's full name, organisation, and country : Di Wu, China National Health Development Research Center, China

Position : intern-researcher

Abstract ID : OT34

Abstract title : How socioeconomic status and the public sector affected the access to diagnosis of malaria in children under five: findings from 19 sub-Saharan African Countries

Presenter's full name, organisation, and country : Ge Yue, Fudan University, China

Position : PhD candidate

Abstract ID : OT37

Abstract title : VIDEO ASSISTED THORACOSCOPIC SURGERY VERSUS OPEN SURGERY FOR NON-SMALL CELL LUNG CANCER IN ELDERLY PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter's full name, organisation, and country : Jungeun Park, National Evidence-based Healthcare Collaborating Agency, South Korea

Position : Researcher

Abstract ID : OT38

Abstract title : Efficacy and safety of monoclonal antibody in patients with neuromyelitis optica spectrum disorder: a systematic review and network meta-analysis

Presenter's full name, organisation, and country : Saharat Aungsumart, Neurological institute of Thailand, Thailand

Position : Physician

Abstract ID : OT40

Abstract title : Mucosal Integrity Testing: systematic review

Presenter's full name, organisation, and country : JINA MO, National Evidence-based Healthcare Collaborating Agency(NECA), South Korea

Position : Associate Research Fellow

Abstract ID : OT45

Abstract title : Depressed and depression-prone groups preference with regard to antidepressants in China: a best-worst scaling survey

Presenter's full name, organisation, and country : Yanfeng Ren, Fudan university, China

Position : None

Abstract ID : OT47

Abstract title : The Economic Evaluation of Screening and Early Diagnosis of Primary Immunodeficiency Diseases: A Systematic Review

Presenter's full name, organisation, and country : Fan Zhang, Wanke School of Public Health, Tsinghua University, China

Position : Research Assistant

Abstract ID : OT48

Abstract title : A scoping review on the transmission of multidrug-resistant organisms in healthcare network settings from a systematic perspective.

Presenter's full name, organisation, and country : Yixue Guo, Fudan University, China

Position : Student

Abstract ID : OT55

Abstract title : Measuring the direct nonmedical cost associated with advanced non-small cell lung cancer in China: Is there a difference in health status?

Presenter's full name, organisation, and country : Yu Xia, NHC Key Lab of Health Technology Assessment, School of Public Health, Fudan University, Shanghai, China, China

Position : PhD student

Abstract ID : OT56

Abstract title : Health-related quality of life for caregivers of patients with advanced non-small cell lung cancer in China

Presenter's full name, organisation, and country : Liu Liu, Fudan university, China

Position : PhD student

Abstract ID	Abstract title	Presenter's full name, organisation, and country	Position
EE03	Cost-benefit analysis and budget impact analysis of Down syndrome screening using Non-Invasive Prenatal Test (NIPT)	Tuangrat Phodha, Faculty of Pharmacy, THAMMASAT UNIVERSITY, Thailand	Lecturer
EE04	Programmatic Cost-Effectiveness of Second Home Visit for Detecting New Tuberculosis (TB) and Diabetes Mellitus in TB Contact Tracing	Nyi Nyi Zayar, Prince of Songkla University, Thailand	Ph.D. student
EE09	Cost-effectiveness of Novel agent regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma patients in India	Dr. Jyoti Dixit, Post Graduate Institute of Medical Education and Research, Chandigarh, India	Project Coordinator (PhD Health Economics)
EE11	COST-UTILITY ANALYSIS OF MOLECULAR TESTING FOR TUBERCULOSIS DIAGNOSIS IN SUSPECTED PULMONARY TUBERCULOSIS IN THAILAND	Natthakan Chitpim, Faculty of Pharmacy, Mahidol University, Thailand	PhD Student
EE16	A cost analysis and economic evaluation of universal newborn hearing screening program in Thailand	Chanida Ekakkararungroj, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research Assistant
EE23	Cost-effectiveness Analysis of universal antenatal serologic cytomegalovirus screening versus targeted screening in Singapore	Zhi Zhen Lim, NUS Saw Swee Hock School of Public Health (HIPER), Singapore	Research Assistant
EE26	Sensitivity Analysis of HPV Extended Genotyping Detection Technology Based on Cervical Cancer Screening Strategy in China	Ping Zhou, Fudan University, China	associate professor
EE34	A systematic review of reporting quality of economic evaluations in TCM in NRDL of China based on CHEERS	Juntao Yan, Fudan University, China	PhD Candidate
EE40	Financing Model for COVID-19 and Routine Immunization Programs in Public and Private Facilities: A Case Study in Bandung, Indonesia	Auliya A. Suwantika, Center for Health Technology Assessment, Universitas Padjadjaran, Indonesia	Researcher
EE44	The status of treatment and economic burden of children with achondroplasia in China	Chengaxin Duan, CNHDRC, China
HS01	The Population’s Preference for Colorectal Cancer Screening Test in Singapore: A Discrete Choice Experiment	Clarence Ong, Saw Swee Hock School of Public Health, National University of Singapore, Singapore	Research Assistant
HS07	Expanding access to SGLT2 Inhibitors (SGLT2i) in the Ministry of Health (MOH) Malaysia – A Multiple HTA approach	Coleen Choo Siew Bee, Pharmaceutical Services Programme, Ministry of Health, Malaysia	Pharmacist
HS08	Biosimilar Medicines in Malaysia – Unveiling New Guidance for Practice	Nurulmaya Ahmad Sa ad, Pharmaceutical Services Programme, Ministry of Health, Malaysia	Pharmacist
HS13	‘Science is only half of it’: Expert perspectives on operationalising infectious disease control cooperation in the ASEAN region	Manit Sittimart, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate
HS17	Scaling up universal newborn hearing screening program in Thailand: A study on the feasibility	VILAWAN LUANKONGSOMCHIT, Health Intervention and Technology Assessment Program (HITAP), Thailand	Research assistant
HS18	Topic Prioritization Framework of the HTA Process	Jason Oliver Simbulan Angeles, Department of Health - Health Technology Assessment, Philippines	Health Program Officer I - Partnerships Officer
HS19	INTEGRATION OF THE WHO ALGORITHM FOR THE NATIONAL ESSENTIAL MEDICINES LIST IN THE PHILIPPINE HTA PROCESS	Norieline C. Cagasan, DOH - Health Technology Assessment Division, Philippines	Health Program Officer II
HS20	Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand	Saranya Sachdev, International Health Policy Program, Thailand	Research Assistant
HS23	Ethical, Legal, Social, and Health Systems Impact Assessment of Oral Pre-Exposure Prophylaxis for HIV in the Philippines	Faisal H. Jackarain, RN, CLSSYB, DOH Health Technology Assessment Division, Philippines	Senior Health Program Officer
HS27	Anthropological perspectives of geriatric population on Health Disparity among elderly people living in rural regions of India.(A study based on 9 villages in Eastern Uttar Pradesh)	Dr. ILHAM ZAIDI, Eqkuiaccess Foundation, India	Consultant
HS28	Cost-of-illness and associated factors among persons with type 2 diabetes: Findings from a tertiary care center in south India	Dr Jeby Jose Olickal, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India	PhD Scholar
HS40	Evaluation of Successful Implementation of Pediatric Sedation Protocol at Chiang Mai University Hospital	Dr.Anutra Khangtragool, Division of Pharmacy, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand	Pharmacist, Expert Level Position Chief of Pharmaceuticals and Medical Devices
OT02	Pragmatic review methods to inform policy/recommendations during COVID-19	Daniella Dougherty, Royal Australasian College of Surgeons - ASERNIP-S, Australia	Senior Research Officer
OT06	COST-EFFECTIVENESS OF CATHETER ABLATION VERSUS ANTIARRHYTHMIC DRUGS FOR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS	Luxzup Wattanasukchai, Mahidol University, Thailand	Student
OT14	CONSEQUENCES OF POSTOPERATIVE COGNITIVE	Patumporn Suraarunsumrit, Mahidol University, Thailand	Assistant Professor
OT26	Content Validity of Cardiovascular Disease-Specific Health-Related Quality of Life Instruments: A Systematic Literature Review and Evaluation	Xue Li, Mcmaster University, Canada	PhD student
OT30	Continue to Advance Global Research on Combating AMR under the Guidance of One Health - based on a bibliometric analysis	Fang Zheyi, Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China, China	student
OT31	Cost-effectiveness analysis of perinatal depression screening: A scoping review	Xinyue Xie, School of Public Health, Fudan University, Key Lab of Health Technology Assessment, National Health Commission, China	Shanghai, China
OT41	A systematic review of health economic evaluations for Indonesia: assessing evidence quality and adherence to the Indonesian Health Technology Assessment Guideline	Kinanti Khansa Chavarina, National University of Singapore, Singapore	Student
OT42	Assessment of Greenhouse Gas (GHG) Emissions from Public Healthcare Facilities in Thailand	Choi Jung Woo, National Evidence-based Healthcare Collaborating Agency, South Korea	Researcher
OT43	ECONOMIC EVALUATIONS OF FIXED-DOSE COMBINATIONS DRUG: A SYSTEMATIC REVIEW	Phung Lam Toi, Health Strategy and Policy Institute (HSPI), Vietnam	Researcher
OT44	Evaluation of high-density electroencephalography applying to diagnose of cognitive disorder in hearing impaired population	Tong Zhou, Fudan University, China	Student
OT52	Pertuzumab for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: A Systematic Review and Meta-Analysis	Patrick Wincy C. Reyes, Department of Health, Philippines	Supervising Health Program Officer
OT53	TO BOOST OR NOT TO BOOST: EVIDENCE GUIDED DECISIONS ON COVID-19 BOOSTER VACCINATION IN THE PHILIPPINES	Sarah May L. Obmana, Health Technology Assessment Division - Philippine Department of Health, Philippines	Senior Health Program Officer
OT54	Measuring GFR: A Systematic Review	Yaoling Wang, China National Health Development Research Center, China	Research Assistant
OT58	The effectiveness of conversational AI services (chatbots) on Covid-19 vaccine confidence and acceptance in Hong Kong, Singapore, and Thailand	Madison Silzle, Health Intervention and Technology Assessment Program (HITAP), Thailand	Project Associate

Abstract ID : EE03

Abstract title : Cost-benefit analysis and budget impact analysis of Down syndrome screening using Non-Invasive Prenatal Test (NIPT)

Presenter's full name, organisation, and country : Tuangrat Phodha, Faculty of Pharmacy, THAMMASAT UNIVERSITY, Thailand

Position : Lecturer

Abstract ID : EE04

Abstract title : Programmatic Cost-Effectiveness of Second Home Visit for Detecting New Tuberculosis (TB) and Diabetes Mellitus in TB Contact Tracing

Presenter's full name, organisation, and country : Nyi Nyi Zayar, Prince of Songkla University, Thailand

Position : Ph.D. student

Abstract ID : EE09

Abstract title : Cost-effectiveness of Novel agent regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma patients in India

Presenter's full name, organisation, and country : Dr. Jyoti Dixit, Post Graduate Institute of Medical Education and Research, Chandigarh, India

Position : Project Coordinator (PhD Health Economics)

Abstract ID : EE11

Abstract title : COST-UTILITY ANALYSIS OF MOLECULAR TESTING FOR TUBERCULOSIS DIAGNOSIS IN SUSPECTED PULMONARY TUBERCULOSIS IN THAILAND

Presenter's full name, organisation, and country : Natthakan Chitpim, Faculty of Pharmacy, Mahidol University, Thailand

Position : PhD Student

Abstract ID : EE16

Abstract title : A cost analysis and economic evaluation of universal newborn hearing screening program in Thailand

Presenter's full name, organisation, and country : Chanida Ekakkararungroj, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research Assistant

Abstract ID : EE23

Abstract title : Cost-effectiveness Analysis of universal antenatal serologic cytomegalovirus screening versus targeted screening in Singapore

Presenter's full name, organisation, and country : Zhi Zhen Lim, NUS Saw Swee Hock School of Public Health (HIPER), Singapore

Position : Research Assistant

Abstract ID : EE26

Abstract title : Sensitivity Analysis of HPV Extended Genotyping Detection Technology Based on Cervical Cancer Screening Strategy in China

Presenter's full name, organisation, and country : Ping Zhou, Fudan University, China

Position : associate professor

Abstract ID : EE34

Abstract title : A systematic review of reporting quality of economic evaluations in TCM in NRDL of China based on CHEERS

Presenter's full name, organisation, and country : Juntao Yan, Fudan University, China

Position : PhD Candidate

Abstract ID : EE40

Abstract title : Financing Model for COVID-19 and Routine Immunization Programs in Public and Private Facilities: A Case Study in Bandung, Indonesia

Presenter's full name, organisation, and country : Auliya A. Suwantika, Center for Health Technology Assessment, Universitas Padjadjaran, Indonesia

Position : Researcher

Abstract ID : EE44

Abstract title : The status of treatment and economic burden of children with achondroplasia in China

Presenter's full name, organisation, and country : Chengaxin Duan, CNHDRC, China

Position :

Abstract ID : HS01

Abstract title : The Population’s Preference for Colorectal Cancer Screening Test in Singapore: A Discrete Choice Experiment

Presenter's full name, organisation, and country : Clarence Ong, Saw Swee Hock School of Public Health, National University of Singapore, Singapore

Position : Research Assistant

Abstract ID : HS07

Abstract title : Expanding access to SGLT2 Inhibitors (SGLT2i) in the Ministry of Health (MOH) Malaysia – A Multiple HTA approach

Presenter's full name, organisation, and country : Coleen Choo Siew Bee, Pharmaceutical Services Programme, Ministry of Health, Malaysia

Position : Pharmacist

Abstract ID : HS08

Abstract title : Biosimilar Medicines in Malaysia – Unveiling New Guidance for Practice

Presenter's full name, organisation, and country : Nurulmaya Ahmad Sa ad, Pharmaceutical Services Programme, Ministry of Health, Malaysia

Position : Pharmacist

Abstract ID : HS13

Abstract title : ‘Science is only half of it’: Expert perspectives on operationalising infectious disease control cooperation in the ASEAN region

Presenter's full name, organisation, and country : Manit Sittimart, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

Abstract ID : HS17

Abstract title : Scaling up universal newborn hearing screening program in Thailand: A study on the feasibility

Presenter's full name, organisation, and country : VILAWAN LUANKONGSOMCHIT, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Research assistant

Abstract ID : HS18

Abstract title : Topic Prioritization Framework of the HTA Process

Presenter's full name, organisation, and country : Jason Oliver Simbulan Angeles, Department of Health - Health Technology Assessment, Philippines

Position : Health Program Officer I - Partnerships Officer

Abstract ID : HS19

Abstract title : INTEGRATION OF THE WHO ALGORITHM FOR THE NATIONAL ESSENTIAL MEDICINES LIST IN THE PHILIPPINE HTA PROCESS

Presenter's full name, organisation, and country : Norieline C. Cagasan, DOH - Health Technology Assessment Division, Philippines

Position : Health Program Officer II

Abstract ID : HS20

Abstract title : Procedural fairness in benefit package design: inclusion of pre-exposure prophylaxis of HIV in Universal Coverage Scheme in Thailand

Presenter's full name, organisation, and country : Saranya Sachdev, International Health Policy Program, Thailand

Position : Research Assistant

Abstract ID : HS23

Abstract title : Ethical, Legal, Social, and Health Systems Impact Assessment of Oral Pre-Exposure Prophylaxis for HIV in the Philippines

Presenter's full name, organisation, and country : Faisal H. Jackarain, RN, CLSSYB, DOH Health Technology Assessment Division, Philippines

Position : Senior Health Program Officer

Abstract ID : HS27

Abstract title : Anthropological perspectives of geriatric population on Health Disparity among elderly people living in rural regions of India.(A study based on 9 villages in Eastern Uttar Pradesh)

Presenter's full name, organisation, and country : Dr. ILHAM ZAIDI, Eqkuiaccess Foundation, India

Position : Consultant

Abstract ID : HS28

Abstract title : Cost-of-illness and associated factors among persons with type 2 diabetes: Findings from a tertiary care center in south India

Presenter's full name, organisation, and country : Dr Jeby Jose Olickal, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India

Position : PhD Scholar

Abstract ID : HS40

Abstract title : Evaluation of Successful Implementation of Pediatric Sedation Protocol at Chiang Mai University Hospital

Presenter's full name, organisation, and country : Dr.Anutra Khangtragool, Division of Pharmacy, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Position : Pharmacist, Expert Level Position Chief of Pharmaceuticals and Medical Devices

Abstract ID : OT02

Abstract title : Pragmatic review methods to inform policy/recommendations during COVID-19

Presenter's full name, organisation, and country : Daniella Dougherty, Royal Australasian College of Surgeons - ASERNIP-S, Australia

Position : Senior Research Officer

Abstract ID : OT06

Abstract title : COST-EFFECTIVENESS OF CATHETER ABLATION VERSUS ANTIARRHYTHMIC DRUGS FOR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS

Presenter's full name, organisation, and country : Luxzup Wattanasukchai, Mahidol University, Thailand

Position : Student

Abstract ID : OT14

Abstract title : CONSEQUENCES OF POSTOPERATIVE COGNITIVE

Presenter's full name, organisation, and country : Patumporn Suraarunsumrit, Mahidol University, Thailand

Position : Assistant Professor

Abstract ID : OT26

Abstract title : Content Validity of Cardiovascular Disease-Specific Health-Related Quality of Life Instruments: A Systematic Literature Review and Evaluation

Presenter's full name, organisation, and country : Xue Li, Mcmaster University, Canada

Position : PhD student

Abstract ID : OT30

Abstract title : Continue to Advance Global Research on Combating AMR under the Guidance of One Health - based on a bibliometric analysis

Presenter's full name, organisation, and country : Fang Zheyi, Key Lab of Health Technology Assessment, National Health Commission of the People’s Republic of China, China

Position : student

Abstract ID : OT31

Abstract title : Cost-effectiveness analysis of perinatal depression screening: A scoping review

Presenter's full name, organisation, and country : Xinyue Xie, School of Public Health, Fudan University, Key Lab of Health Technology Assessment, National Health Commission, China

Position : Shanghai, China

Abstract ID : OT41

Abstract title : A systematic review of health economic evaluations for Indonesia: assessing evidence quality and adherence to the Indonesian Health Technology Assessment Guideline

Presenter's full name, organisation, and country : Kinanti Khansa Chavarina, National University of Singapore, Singapore

Position : Student

Abstract ID : OT42

Abstract title : Assessment of Greenhouse Gas (GHG) Emissions from Public Healthcare Facilities in Thailand

Presenter's full name, organisation, and country : Choi Jung Woo, National Evidence-based Healthcare Collaborating Agency, South Korea

Position : Researcher

Abstract ID : OT43

Abstract title : ECONOMIC EVALUATIONS OF FIXED-DOSE COMBINATIONS DRUG: A SYSTEMATIC REVIEW

Presenter's full name, organisation, and country : Phung Lam Toi, Health Strategy and Policy Institute (HSPI), Vietnam

Position : Researcher

Abstract ID : OT44

Abstract title : Evaluation of high-density electroencephalography applying to diagnose of cognitive disorder in hearing impaired population

Presenter's full name, organisation, and country : Tong Zhou, Fudan University, China

Position : Student

Abstract ID : OT52

Abstract title : Pertuzumab for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: A Systematic Review and Meta-Analysis

Presenter's full name, organisation, and country : Patrick Wincy C. Reyes, Department of Health, Philippines

Position : Supervising Health Program Officer

Abstract ID : OT53

Abstract title : TO BOOST OR NOT TO BOOST: EVIDENCE GUIDED DECISIONS ON COVID-19 BOOSTER VACCINATION IN THE PHILIPPINES

Presenter's full name, organisation, and country : Sarah May L. Obmana, Health Technology Assessment Division - Philippine Department of Health, Philippines

Position : Senior Health Program Officer

Abstract ID : OT54

Abstract title : Measuring GFR: A Systematic Review

Presenter's full name, organisation, and country : Yaoling Wang, China National Health Development Research Center, China

Position : Research Assistant

Abstract ID : OT58

Abstract title : The effectiveness of conversational AI services (chatbots) on Covid-19 vaccine confidence and acceptance in Hong Kong, Singapore, and Thailand

Presenter's full name, organisation, and country : Madison Silzle, Health Intervention and Technology Assessment Program (HITAP), Thailand

Position : Project Associate

30 November - 2 December 2022

Tel: (+66)2-590-4549, (+66)2-590-4374-5

Email: htasialinkconf@hitap.net,

htasialink2022@hitap.net

Fax: (+66)2-590-4369

Plenary 1 : Reimagining the Post-COVID Health System and HTA

Plenary 2 : Accelerating the Impact of Real-World Evidence in Global HTA Community

Plenary 3 : Searching for the Holy Grail Solution for Our Health Systems : Are Disruptive Technologies the Answer?

Explore Nong Nooch Tropical Botanical Garden

Discover the Sanctuary of Truth

Take a Day Trip to Koh Larn (Coral Island)

Accepted Abstracts